Answers are grounded in this paper and cite their sources.
Temporomandibular disorders (TMDs) are often accompanied by inflammatory conditions such as joint monoarthritis that cause progressive structural degradation. However, conventional monotherapies offer only limited relief, but combined neurotoxin and biomodulatory approaches are a promising alternative that needs systematic histological evaluation. The aim of this study was to evaluate the histological and Histomorphometric effect of combined photobiomodulation (PBM) and botulinum toxin type-A (BTX-A) compared to the monotherapy of each treatment in a rat model of complete Freund’s adjuvant (CFA)-induced temporomandibular joint (TMJ) monoarthritis. Forty Wistar male rats were injected unilaterally with 100 µL (1 mg/mL) of complete Freund’s adjuvant (CFA) intra-articularly in the left temporomandibular joint (TMJ) area and then divided into four groups: untreated CFA control group, PBM received group (980 nm, 0.5 W, 20 J/cm², four sessions), BTX-A injection group (5 units intramuscular) and combined PBM + BTX-A group. Three weeks after CFA injection, mandibular condyles, synovial tissue and masseter muscles were harvested for histological analysis. The combined therapy group achieved superior results in organization of cartilage zones, subchondral bone architecture, synovial membrane architecture and muscle fiber alignment in comparison with the active untreated TMJ monoarthritis group (Group I). Moreover, the combined PBM + BTX-A group had a significantly lower chondroblastic thickness and significantly higher hypertrophic thickness compared to all other groups (p < 0.05). Correlation analysis showed a strong positive correlation between the chondroblastic and hypertrophic zones only in the untreated CFA group (r = 0.934, p < 0.001). Combined PBM and BTX-A therapy demonstrated superior structural tissue recovery in an experimentally induced rat model of TMJ monoarthritis compared to monotherapies or untreated control, establishing an effective multimodal framework that addresses inflammatory and neuromuscular components of the disease simultaneously.
No takes yet. Share an insight, caveat, or question.
Emam et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: